| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.0066 | 1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0061 | 1 |